Test-retest variability of multifocal electroretinography in normal volunteers and short-term variability in hydroxychloroquine users

David J Browning,1 Chong Lee2 1Charlotte Eye, Ear, Nose and Throat Associates, 2University of North Carolina – Charlotte, Charlotte, NC, USA Purpose: To determine measurement variability of N1P1 amplitudes and the R1/R2 ratio in normal subjects and hydroxychloroquine users without retino...

Full description

Bibliographic Details
Main Authors: Browning DJ, Lee C
Format: Article
Language:English
Published: Dove Medical Press 2014-08-01
Series:Clinical Ophthalmology
Online Access:http://www.dovepress.com/test-retest-variability-of-multifocal-electroretinography-in-normal-vo-peer-reviewed-article-OPTH
_version_ 1818909604444110848
author Browning DJ
Lee C
author_facet Browning DJ
Lee C
author_sort Browning DJ
collection DOAJ
description David J Browning,1 Chong Lee2 1Charlotte Eye, Ear, Nose and Throat Associates, 2University of North Carolina – Charlotte, Charlotte, NC, USA Purpose: To determine measurement variability of N1P1 amplitudes and the R1/R2 ratio in normal subjects and hydroxychloroquine users without retinopathy. Design: Retrospective, observational study. Subjects: Normal subjects (n=21) and 44 patients taking hydroxychloroquine (n=44) without retinopathy. Methods: Multifocal electroretinography (mfERG) was performed twice in one session in the 21 normal subjects and twice within 1 year in the hydroxychloroquine users, during which time no clinical change in macular status occurred. Main outcome measures: N1P1 amplitudes of rings R1–R5, the R1/R2 ratio, and coefficients of repeatability (COR) for these measurements. Results: Values for N1P1 amplitudes in hydroxychloroquine users were reduced compared with normal subjects by the known effect of age, but R1/R2 was not affected by age. The COR for R1–R5 ranged from 43% to 52% for normal subjects and from 43% to 59% for hydroxychloroquine users; for R1/R2 the COR was 29% in normal subjects and 45% in hydroxychloroquine users. Conclusion: mfERG measurements show high test-retest variability, limiting the ability of a single mfERG test to influence a decision to stop hydroxychloroquine; corroborative evidence with a different ancillary test is recommended in a suspicious case. Keywords: multifocal electroretinography, hydroxychloroquine, test-retest variability 
first_indexed 2024-12-19T22:29:33Z
format Article
id doaj.art-09e90a6126bd4aca97313e6b8ee6d0f2
institution Directory Open Access Journal
issn 1177-5483
language English
last_indexed 2024-12-19T22:29:33Z
publishDate 2014-08-01
publisher Dove Medical Press
record_format Article
series Clinical Ophthalmology
spelling doaj.art-09e90a6126bd4aca97313e6b8ee6d0f22022-12-21T20:03:22ZengDove Medical PressClinical Ophthalmology1177-54832014-08-012014default1467147317868Test-retest variability of multifocal electroretinography in normal volunteers and short-term variability in hydroxychloroquine usersBrowning DJLee CDavid J Browning,1 Chong Lee2 1Charlotte Eye, Ear, Nose and Throat Associates, 2University of North Carolina – Charlotte, Charlotte, NC, USA Purpose: To determine measurement variability of N1P1 amplitudes and the R1/R2 ratio in normal subjects and hydroxychloroquine users without retinopathy. Design: Retrospective, observational study. Subjects: Normal subjects (n=21) and 44 patients taking hydroxychloroquine (n=44) without retinopathy. Methods: Multifocal electroretinography (mfERG) was performed twice in one session in the 21 normal subjects and twice within 1 year in the hydroxychloroquine users, during which time no clinical change in macular status occurred. Main outcome measures: N1P1 amplitudes of rings R1–R5, the R1/R2 ratio, and coefficients of repeatability (COR) for these measurements. Results: Values for N1P1 amplitudes in hydroxychloroquine users were reduced compared with normal subjects by the known effect of age, but R1/R2 was not affected by age. The COR for R1–R5 ranged from 43% to 52% for normal subjects and from 43% to 59% for hydroxychloroquine users; for R1/R2 the COR was 29% in normal subjects and 45% in hydroxychloroquine users. Conclusion: mfERG measurements show high test-retest variability, limiting the ability of a single mfERG test to influence a decision to stop hydroxychloroquine; corroborative evidence with a different ancillary test is recommended in a suspicious case. Keywords: multifocal electroretinography, hydroxychloroquine, test-retest variability http://www.dovepress.com/test-retest-variability-of-multifocal-electroretinography-in-normal-vo-peer-reviewed-article-OPTH
spellingShingle Browning DJ
Lee C
Test-retest variability of multifocal electroretinography in normal volunteers and short-term variability in hydroxychloroquine users
Clinical Ophthalmology
title Test-retest variability of multifocal electroretinography in normal volunteers and short-term variability in hydroxychloroquine users
title_full Test-retest variability of multifocal electroretinography in normal volunteers and short-term variability in hydroxychloroquine users
title_fullStr Test-retest variability of multifocal electroretinography in normal volunteers and short-term variability in hydroxychloroquine users
title_full_unstemmed Test-retest variability of multifocal electroretinography in normal volunteers and short-term variability in hydroxychloroquine users
title_short Test-retest variability of multifocal electroretinography in normal volunteers and short-term variability in hydroxychloroquine users
title_sort test retest variability of multifocal electroretinography in normal volunteers and short term variability in hydroxychloroquine users
url http://www.dovepress.com/test-retest-variability-of-multifocal-electroretinography-in-normal-vo-peer-reviewed-article-OPTH
work_keys_str_mv AT browningdj testretestvariabilityofmultifocalelectroretinographyinnormalvolunteersandshorttermvariabilityinhydroxychloroquineusers
AT leec testretestvariabilityofmultifocalelectroretinographyinnormalvolunteersandshorttermvariabilityinhydroxychloroquineusers